|
|
|
Gritstone Oncology Inc 
|
17.3 -3.26 (-0.16%) |
01-27 16:00 |
Open: |
19.72 |
Pre close: |
20.56 |
Target:
|
26.84
|
High: |
20.6299 |
Low: |
17.25 |
Resistance:
|
22.98
35.20 
|
Volume: |
2,882,806 |
Market Cap: |
819M |
Support:
|
3.21
2.67
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
22.88
 |
MACD |
MACD(12,26):
|
4.93  |
MA(20): |
11.45  |
Signal(12,26,9): |
3.84  |
MA(100): |
4.68  |
Stochastic Oscillator |
%K(14,3):
|
52.18  |
MA(250): |
5.62  |
%D(3): |
61.55  |
Average Volume(K) |
3-Month: |
288102
|
52-Week |
High:
|
35.20 |
10-Days: |
1486868 |
Low: |
2.54 |
RSI |
RSI(14):
|
61.55  |
Change(%): |
78.5 |
Financials, Statistics and Valuation |
EPS |
-2.870 |
Return on Equity (ttm) |
-92.7 |
Shares Out. (M) |
47.35 |
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-40.5 |
Shares Float (M) |
12.25 |
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
9.02 |
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-4.6 |
% Held by Institutions |
65.43 |
Forward EPS |
-2.810 |
Gross Profit (p.s.) |
-1.659 |
Shares Short (K) |
1860 |
Book Value (p.s.) |
1.910 |
EBITDA (p.s.) |
-2.129 |
P/E |
-6.03 |
Sales Per Share |
0.075 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.06 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-86.34 |
P/S |
229.46 |
Operating Margin |
-3000.64 |
Levered Free Cash Flow
(M) |
-64.78 |
P/CF |
-9.49 |
|
|
|
|
|